Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Folding for the Immune Synapse: CCT Chaperonin and the Cytoskeleton.

  • Martin-Cofreces, Noa B.
  • Valpuesta, Jose Maria
  • Sanchez-Madrid, Francisco
Lymphocytes rearrange their shape, membrane receptors and organelles during cognate contacts with antigen-presenting cells (APCs). Activation of T cells by APCs through pMHC-TCR/CD3 interaction (peptide-major histocompatibility complex-T cell receptor/CD3 complexes) involves different steps that lead to the reorganization of the cytoskeleton and organelles and, eventually, activation of nuclear factors allowing transcription and ultimately, replication and cell division. Both the positioning of the lymphocyte centrosome in close proximity to the APC and the nucleation of a dense microtubule network beneath the plasma membrane from the centrosome support the T cell's intracellular polarity. Signaling from the TCR is facilitated by this traffic, which constitutes an important pathway for regulation of T cell activation. The coordinated enrichment upon T cell stimulation of the chaperonin CCT (chaperonin-containing tailless complex polypeptide 1; also termed TRiC) and tubulins at the centrosome area support polarized tubulin polymerization and T cell activation. The proteasome is also enriched in the centrosome of activated T cells, providing a mechanism to balance local protein synthesis and degradation. CCT assists the folding of proteins coming from de novo synthesis, therefore favoring mRNA translation. The functional role of this chaperonin in regulating cytoskeletal composition and dynamics at the immune synapse is discussed.
Repisalud
Publicación Artículo científico (JournalArticle)

CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis.

  • Cibrian, Danay
  • Saiz, María Laura
  • de la Fuente, Hortensia
  • Sánchez-Díaz, Raquel
  • Moreno-Gonzalo, Olga
  • Jorge, Inmaculada
  • Ferrarini, Alessia
  • Vázquez, Jesús
  • Punzón, Carmen
  • Fresno, Manuel
  • Vicente-Manzanares, Miguel
  • Daudén, Esteban
  • Fernández-Salguero, Pedro M
  • Martín, Pilar
  • Sánchez-Madrid, Francisco
The activation marker CD69 is expressed by skin γδ T cells. Here we found that CD69 controlled the aryl hydrocarbon receptor (AhR)-dependent secretion of interleukin 22 (IL-22) by γδ T cells, which contributed to the development of psoriasis induced by IL-23. CD69 associated with the aromatic-amino-acid-transporter complex LAT1-CD98 and regulated its surface expression and uptake of L-tryptophan (L-Trp) and the intracellular quantity of L-Trp-derived activators of AhR. In vivo administration of L-Trp, an inhibitor of AhR or IL-22 abrogated the differences between CD69-deficient mice and wild-type mice in skin inflammation. We also observed LAT1-mediated regulation of AhR activation and IL-22 secretion in circulating Vγ9(+) γδ T cells of psoriatic patients. Thus, CD69 serves as a key mediator of the pathogenesis of psoriasis by controlling LAT1-CD98-mediated metabolic cues.
Repisalud
Publicación Artículo científico (JournalArticle)

A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.

  • Blanco-Domínguez, Rafael
  • Sánchez-Díaz, Raquel
  • de la Fuente, Hortensia
  • Jiménez-Borreguero, Luis J
  • Matesanz-Marín, Adela
  • Relaño, Marta
  • Jiménez-Alejandre, Rosa
  • Linillos-Pradillo, Beatriz
  • Tsilingiri, Katerina
  • Martín-Mariscal, María L
  • Alonso-Herranz, Laura
  • Moreno, Guillermo
  • Martín-Asenjo, Roberto
  • García-Guimaraes, Marcos M
  • Bruno, Katelyn A
  • Dauden, Esteban
  • González-Álvaro, Isidoro
  • Villar-Guimerans, Luisa M
  • Martínez-León, Amaia
  • Salvador-Garicano, Ane M
  • Michelhaugh, Sam A
  • Ibrahim, Nasrien E
  • Januzzi, James L
  • Kottwitz, Jan
  • Iliceto, Sabino
  • Plebani, Mario
  • Basso, Cristina
  • Baritussio, Anna
  • Seguso, Mara
  • Marcolongo, Renzo
  • Ricote, Mercedes
  • Fairweather, DeLisa
  • Bueno, Hector
  • Fernández-Friera, Leticia
  • Alfonso, Fernando
  • Caforio, Alida L P
  • Pascual-Figal, Domingo A
  • Heidecker, Bettina
  • Lüscher, Thomas F
  • Das, Saumya
  • Fuster, Valentin
  • Ibáñez, Borja
  • Sánchez-Madrid, Francisco
  • Martin, Pilar
The diagnosis of acute myocarditis typically requires either endomyocardial biopsy (which is invasive) or cardiovascular magnetic resonance imaging (which is not universally available). Additional approaches to diagnosis are desirable. We sought to identify a novel microRNA for the diagnosis of acute myocarditis. To identify a microRNA specific for myocarditis, we performed microRNA microarray analyses and quantitative polymerase-chain-reaction (qPCR) assays in sorted CD4+ T cells and type 17 helper T (Th17) cells after inducing experimental autoimmune myocarditis or myocardial infarction in mice. We also performed qPCR in samples from coxsackievirus-induced myocarditis in mice. We then identified the human homologue for this microRNA and compared its expression in plasma obtained from patients with acute myocarditis with the expression in various controls. We confirmed that Th17 cells, which are characterized by the production of interleukin-17, are a characteristic feature of myocardial injury in the acute phase of myocarditis. The microRNA mmu-miR-721 was synthesized by Th17 cells and was present in the plasma of mice with acute autoimmune or viral myocarditis but not in those with acute myocardial infarction. The human homologue, designated hsa-miR-Chr8:96, was identified in four independent cohorts of patients with myocarditis. The area under the receiver-operating-characteristic curve for this novel microRNA for distinguishing patients with acute myocarditis from those with myocardial infarction was 0.927 (95% confidence interval, 0.879 to 0.975). The microRNA retained its diagnostic value in models after adjustment for age, sex, ejection fraction, and serum troponin level. After identifying a novel microRNA in mice and humans with myocarditis, we found that the human homologue (hsa-miR-Chr8:96) could be used to distinguish patients with myocarditis from those with myocardial infarction. (Funded by the Spanish Ministry of Science and Innovation and others.).